Carbaglu
NDC 52276-312, Carglumic Acid, tablet, for suspension, from Recordati Rare Diseases.
- Product NDC
- 52276-312
- Status
- Listed
- Labeler
- Recordati Rare Diseases
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022562
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/52276-312 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CARGLUMIC ACID200 mg/1
Pharmacologic classes
Carbamoyl Phosphate Synthetase 1 Activator [EPC]; Carbamoyl Phosphate Synthetase 1 Activators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 52276-312-05 | 52276031205 | 5 TABLET, FOR SUSPENSION in 1 BOTTLE (52276-312-05) |
| 52276-312-60 | 52276031260 | 60 TABLET, FOR SUSPENSION in 1 BOTTLE (52276-312-60) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/10175e73-5172-4dde-a508-8a88b7afc0a1
Use it
Look up 52276-312 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/52276-312 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 52276-312. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.